Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response

Diabetes Therapy · Published 2026-06-15 · DOI 10.1007/s13300-026-01888-y

Free full text

Authors (12)

Muhammad Hamid Siddique Mian, Kholood Abdulla Hasan Abdulla Janahi, Afnan Tayeb, Fathima Musfira Mohamad Musaffar, Nur Al Sheykh Khalil, Sarah Hisham Al Toubah, Abdul Moen Abdul Karim, Ahlam Almarzooqi, Fardeen Mohammad Sayfoo, Ahmed Hamadeh, Mohannad Abdulla Hasan Abdulla Janahi, Sobia Siddiq

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mian, M., Janahi, K., Tayeb, A., et al. (2026). Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response. Diabetes Therapy. https://doi.org/10.1007/s13300-026-01888-y

Related articles

• Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece · Diabetes Therapy · 2026 · Same journal
• Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category · Diabetes Therapy · 2026 · Same journal
• Insulin Injection Behaviors and Association with Glycemic Outcomes in Patients with Diabetes: A Real-World Survey in Spain · Diabetes Therapy · 2026 · Same journal
• Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review · Diabetes Therapy · 2026 · Same journal
• A Retrospective Analysis of the Clinical Characteristics and Treatment Patterns Among Individuals with Diabetes Receiving Insulin Therapy in Japan: The Insulin JP2DB Study · Diabetes Therapy · 2026 · Same journal
• Glycemic Patterns Assessed by Continuous Glucose Monitoring in People with Type 2 Diabetes Treated with Insulin Glargine 100 U/mL in Primary Care: The GPDetect Study · Diabetes Therapy · 2026 · Same journal
• Beyond Coverage Expansion: Exploring Persistent Barriers to CGM Utilization in the Clinical Environment · Diabetes Therapy · 2026 · Same journal
• Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes · Diabetes Therapy · 2026 · Same journal
• Continuous Glucose Monitoring Before and After Simultaneous Pancreas–Kidney Transplantation: Insights from a Real-World Clinical Setting · Diabetes Therapy · 2026 · Same journal
• Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG · Diabetes Therapy · 2026 · Same journal